Radiopharm Appoints New Director, No Securities Held

Radiopharm Theranostics Limited (AU:RAD) has released an update.

Radiopharm Theranostics Limited has announced the appointment of Mr. Noel Donnelly as a director of the company as of October 1, 2024. According to the Initial Director’s Interest Notice provided to the ASX, Mr. Donnelly currently holds no securities in the company. This notice complies with listing rule 3.19A.1 and section 205G of the Corporations Act.

For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.